Security key
23284F105
CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share ("Common Stock") (CTMX)
CUSIP: 23284F105
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock, $0.00001 par value per share ("Common Stock")
- Shares outstanding
- 217,079,600
- Total 13F shares
- 45,579,430
- Share change
- -7,947,264
- Total reported value
- $83,410,352
- Put/Call ratio
- 0%
- Price per share
- $1.83
- Number of holders
- 86
- Value change
- -$17,825,825
- Number of buys
- 43
- Number of sells
- 64
Report period
Q2 2022
Institutions
86
Top holders
10
CTMX full security history
Newer quarter: Q3 2022
Previous quarter: Q1 2022
CytomX Therapeutics, Inc. SEC filings
CytomX Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 23284F105
Recent filing periods:
Top shareholders of CTMX - CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share ("Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BVF INC/IL |
13F
|
Company |
2.7%
|
5,803,700
|
$15,496,000 | — | 31 Mar 2022 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
2.7%
|
5,779,700
|
$15,432,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.4%
|
5,222,886
|
$13,945,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.3%
|
4,992,094
|
$13,328,000 | — | 31 Mar 2022 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
2%
|
4,371,300
|
$11,671,000 | — | 31 Mar 2022 | |
| Rubric Capital Management LP |
13F
|
Company |
1.1%
|
2,406,449
|
$6,425,000 | — | 31 Mar 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1%
|
2,245,190
|
$5,995,000 | — | 31 Mar 2022 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.98%
|
2,124,975
|
$5,674,000 | — | 31 Mar 2022 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.92%
|
2,000,000
|
$5,340,000 | — | 31 Mar 2022 | |
| S.c.a. Candriam |
13F
|
Individual |
0.76%
|
1,653,878
|
$4,416,000 | — | 31 Mar 2022 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.59%
|
1,290,600
|
$3,446,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.55%
|
1,198,682
|
$3,200,000 | — | 31 Mar 2022 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.5%
|
1,075,110
|
$2,871,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.48%
|
1,050,148
|
$2,803,000 | — | 31 Mar 2022 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.45%
|
980,085
|
$2,617,000 | — | 31 Mar 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.41%
|
895,900
|
$2,392,000 | — | 31 Mar 2022 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.41%
|
885,107
|
$2,362,000 | — | 31 Mar 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.37%
|
809,140
|
$2,161,000 | — | 31 Mar 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.35%
|
758,589
|
$2,026,000 | — | 31 Mar 2022 | |
| FMR LLC |
13F
|
Company |
0.32%
|
701,804
|
$1,874,000 | — | 31 Mar 2022 | |
| Altium Capital Management LLC |
13F
|
Company |
0.31%
|
663,800
|
$1,772,000 | — | 31 Mar 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.3%
|
661,063
|
$1,765,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.26%
|
573,435
|
$1,531,000 | — | 31 Mar 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.23%
|
491,776
|
$1,313,000 | — | 31 Mar 2022 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
0.16%
|
353,115
|
$943,000 | — | 31 Mar 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.16%
|
348,300
|
$930,000 | — | 31 Mar 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.14%
|
305,032
|
$814,000 | — | 31 Mar 2022 | |
| AXA S.A. |
13F
|
Company |
0.11%
|
242,100
|
$646,407 | — | 31 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.1%
|
212,293
|
$567,000 | — | 31 Mar 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.09%
|
200,943
|
$621,000 | — | 31 Mar 2022 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.09%
|
200,199
|
$535,000 | — | 31 Mar 2022 | |
| Clearline Capital LP |
13F
|
Company |
0.09%
|
190,600
|
$509,000 | — | 31 Mar 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.08%
|
169,951
|
$454,000 | — | 31 Mar 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.08%
|
167,178
|
$447,000 | — | 31 Mar 2022 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.08%
|
162,997
|
$435,000 | — | 31 Mar 2022 | |
| PDT Partners, LLC |
13F
|
Company |
0.06%
|
138,123
|
$369,000 | — | 31 Mar 2022 | |
| XTX Topco Ltd |
13F
|
Company |
0.05%
|
118,339
|
$316,000 | — | 31 Mar 2022 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.05%
|
114,005
|
$304,000 | — | 31 Mar 2022 | |
| STRS OHIO |
13F
|
Company |
0.05%
|
106,900
|
$285,000 | — | 31 Mar 2022 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.05%
|
106,761
|
$285,000 | — | 31 Mar 2022 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.04%
|
87,671
|
$234,000 | — | 31 Mar 2022 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.04%
|
85,379
|
$227,000 | — | 31 Mar 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.04%
|
85,231
|
$228,000 | — | 31 Mar 2022 | |
| Private Advisor Group, LLC |
13F
|
Company |
0.04%
|
84,179
|
$224,000 | — | 31 Mar 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
81,801
|
$218,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
77,619
|
$206,000 | — | 31 Mar 2022 | |
| GLOBEFLEX CAPITAL L P |
13F
|
Company |
0.03%
|
69,435
|
$185,000 | — | 31 Mar 2022 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.03%
|
68,259
|
$182,000 | — | 31 Mar 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.03%
|
67,376
|
$180,000 | — | 31 Mar 2022 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.03%
|
67,211
|
$179,000 | — | 31 Mar 2022 |
Institutional Holders of CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share ("Common Stock") (CTMX) as of Q2 2022
As of 30 Jun 2022,
CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share ("Common Stock") (CTMX) was held by
86 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,579,430 shares.
The largest 10 holders included
BVF INC/IL, VANGUARD GROUP INC, RTW INVESTMENTS, LP, Point72 Asset Management, L.P., Rubric Capital Management LP, ORBIMED ADVISORS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., ACADIAN ASSET MANAGEMENT LLC, BlackRock Inc., and Candriam S.C.A..
This page lists
87
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
112
Q2 2022 holders
86
Holder diff
-26
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.